Ongoing challenges of a global international patient assistance program

The Glivec International Patient Assistance Program (GIPAP™) that is supported by Novartis Oncology provides Glivec (imatinib), an innovative oral therapy for chronic myelogenous leukemia and gastrointestinal stromal tumours, at no cost to patients in developing countries who could otherwise not aff...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephanie Lassarat, S. Jootar
Other Authors: Global Patient Access
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/23017
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Be the first to leave a comment!
You must be logged in first